UNICHEM LABORATORIES
Back to Balance Sheet
|
UNICHEM LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹121 Cr | ₹32 Cr | ₹151 Cr | ₹145 Cr | ₹152 Cr |
What is the latest Contingent Liabilities ratio of UNICHEM LABORATORIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹121 Cr |
| Mar2024 | ₹32 Cr |
| Mar2023 | ₹151 Cr |
| Mar2022 | ₹145 Cr |
| Mar2021 | ₹152 Cr |
How is Contingent Liabilities of UNICHEM LABORATORIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹121 Cr | 284.07 | |
| Mar2024 | ₹32 Cr | -79.14 | |
| Mar2023 | ₹151 Cr | 3.88 | |
| Mar2022 | ₹145 Cr | -4.13 | |
| Mar2021 | ₹152 Cr | - | |
Compare Contingent Liabilities of peers of UNICHEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| UNICHEM LABORATORIES | ₹2,326.7 Cr | -6.9% | -11.6% | -47.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,531.0 Cr | 1.3% | 8.9% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,989.0 Cr | 2.4% | 6% | 12.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,936.0 Cr | -0.6% | 9.4% | 44.1% | Stock Analytics | |
| CIPLA | ₹109,200.0 Cr | 1.9% | 2% | -8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,057.0 Cr | -0.4% | 9.5% | 10.5% | Stock Analytics | |
UNICHEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| UNICHEM LABORATORIES | -6.9% |
-11.6% |
-47.1% |
| SENSEX | -3.7% |
-2.5% |
6.5% |
You may also like the below Video Courses